Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ghadimi

Showing results (201-210 of 280) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignantTanja Fehm, Arthur Sagalowsky, Edward Clifford, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 20, 2018
Risk stratification for postoperative pancreatic fistula using the pancreatic surgery registry StuDoQ|Pancreas of the German Society for General and Visceral SurgeryEkaterina Petrova, Hryhoriy Lapshyn, Dirk Bausch, et al.
Surgery|October 18, 2011
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancerPeter Jo, Klaus Jung, Marian Grade, et al.
Oncotarget|September 28, 2014
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancerJochen Gaedcke, Andreas Leha, Rainer Claus, et al.
International Journal of Molecular Sciences|February 11, 2016
Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) AnalysisRoland S Croner, Müzeyyen Sevim, Metodi V Metodiev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic CancerJian Wang, Shouhui Yang, Peijun He, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Pageof 28

Showing results (201-210 of 280) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignantTanja Fehm, Arthur Sagalowsky, Edward Clifford, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 20, 2018
Risk stratification for postoperative pancreatic fistula using the pancreatic surgery registry StuDoQ|Pancreas of the German Society for General and Visceral SurgeryEkaterina Petrova, Hryhoriy Lapshyn, Dirk Bausch, et al.
Surgery|October 18, 2011
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancerPeter Jo, Klaus Jung, Marian Grade, et al.
Oncotarget|September 28, 2014
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancerJochen Gaedcke, Andreas Leha, Rainer Claus, et al.
International Journal of Molecular Sciences|February 11, 2016
Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) AnalysisRoland S Croner, Müzeyyen Sevim, Metodi V Metodiev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic CancerJian Wang, Shouhui Yang, Peijun He, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Pageof 28